Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

Clinical trial NCT02690181 · COMPLETED

Trial details

NCT number: NCT02690181
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bacterial Infection Due to Streptococcus, Group B Streptococcus Agalactiae

Start date: 2016-03-29
Primary completion: 2016-11-02
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.